U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Active
First Use: Sep-05-2017
First Use in Commerce: Sep-05-2017
Name | HERSCHEL PEREL |
---|---|
Address | Teva Pharmaceuticals USA Inc 425 Privet Rd Horsham, PA 19044-1220 |
Date | Description | Action Tags | Code |
---|---|---|---|
Dec-05-2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | REM1E | |
Dec-05-2017 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Oct-31-2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | SUNAE | |
Oct-28-2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | CNPRP | |
Sep-28-2017 | STATEMENT OF USE PROCESSING COMPLETE | SUPCI | |
Sep-14-2017 | USE AMENDMENT FILED | IUAFS | |
Sep-25-2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | AITUA | |
Sep-14-2017 | TEAS STATEMENT OF USE RECEIVED | EISUI | |
Apr-01-2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Mar-30-2017 | SOU EXTENSION 2 GRANTED | EX2GS | |
Mar-30-2017 | SOU EXTENSION 2 FILED | EXT2S | |
Mar-30-2017 | TEAS EXTENSION RECEIVED | EEXTI | |
Sep-30-2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Sep-28-2016 | SOU EXTENSION 1 GRANTED | EX1GS | |
Sep-28-2016 | SOU EXTENSION 1 FILED | EXT1S | |
Sep-28-2016 | TEAS EXTENSION RECEIVED | EEXTI | |
Apr-05-2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Feb-09-2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Feb-09-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Jan-20-2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Dec-31-2015 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Dec-30-2015 | ASSIGNED TO EXAMINER | DOCKD | |
Sep-18-2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | NWOSI | |
Sep-18-2015 | NEW APPLICATION ENTERED IN TRAM | NWAPI |